IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

B Group, Inc.

Q1 2025 Holdings

Filed 2025-05-15 | 19 holdings | $116.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$46.0M2,317,54239.4%
Insmed Inc(INSM)COM PAR $.01457669307$20.0M262,50017.2%
ZAI LAB LTD(ZLAB)ADR98887Q104$14.5M400,00012.4%
Akero Therapeutics Inc(AKRO)COM00973Y108$9.8M242,5008.4%
Iovance Biotherapeutics Inc(IOVA)COM462260100$5.0M1,500,0004.3%
Cellectis S A(CLLS)SPON ADS15117K103$4.0M3,256,5013.5%
Aura Biosciences Inc(AURA)COM05153U107$2.8M472,5762.4%
Sight Sciences Inc(SGHT)COM82657M105$2.0M833,6001.7%
Assembly Biosciences Inc(ASMB)COM NEW045396207$1.9M200,0001.6%
Taysha Gene Therapies Inc(TSHA)COM SHS877619106$1.7M1,255,5561.5%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$1.7M47,5001.5%
Biontech SE(BNTX)SPONSORED ADS09075V102$1.4M15,0001.2%
Ultragenyx Pharmaceutical inCallCALL90400D908$1.4M37,6001.2%
Spyre Therapeutics Inc(SYRE)COM NEW00773J202$1.1M70,0001.0%
Apogee Therapeutics Inc(APGE)COM03770N101$1.1M30,0001.0%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$719.5K19,0000.6%
89Bio Inc(ETNBGBP)COM282559103$695.2K95,6230.6%
Oruka Therapeutics Inc(ORKA)COM687604108$597.3K58,2150.5%
Corvus Pharmaceuticals IncPutPUT221015950$286.2K90,0000.2%